drugset

drugset / Trial / NCT04662788

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

NCT04662788 ↗

Phase 0 Not yet recruiting 36 enrolled Zhejiang University

NaSingle-groupOpen-labelTreatment

Summary

Clinical study on the safety and effectiveness of NK cells/combined monoclonal antibodies in the treatment of hematological malignancies

Timeline

Start: 2021-01-01
Primary completion: 2024-01-01
Completion: 2027-01-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TROCULEUCEL	Cell therapy	—	—

Indications